Clinical Research Directory
Browse clinical research sites, groups, and studies.
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
Sponsor: ONY
Summary
The purpose of this clinical study is to determine the effectiveness and safety of Infasurf® administered through the InfasurfAero™, a novel oral airway delivery device specifically designed to give Infasurf in a less complicated way and without the need for a breathing tube or interrupting nasal respiratory support.
Official title: InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS: A Single-dose, Double-blind, Random Allocation, Sham-control, Clinical Trial
Key Details
Gender
All
Age Range
29 Weeks - 36 Weeks
Study Type
INTERVENTIONAL
Enrollment
220
Start Date
2025-01-01
Completion Date
2026-04-01
Last Updated
2025-03-30
Healthy Volunteers
No
Interventions
Infasurf Aero™
A single dose of Calfactant administered by pacifier interface by inhalation via the Infasurf Aero nebulizer at 6ml/kg.
Locations (10)
St. Josephs Hospital and Medical Center
Phoenix, Arizona, United States
Phoenix Children's
Phoenix, Arizona, United States
Sharp Mary Birch Hospital for Women & Newborns
San Diego, California, United States
University of Florida -Jacksonville
Jacksonville, Florida, United States
Kapi'olani Medical Center for Women & Children
Honolulu, Hawaii, United States
Jersey Shore University Medical Center
Neptune City, New Jersey, United States
Sisters of Charity Hospital
Buffalo, New York, United States
Western TN- Jackson-Madison County General Hospital
Jackson, Tennessee, United States
Utah Valley Hospital
Provo, Utah, United States
Unity Point Meriter
Madison, Wisconsin, United States